Before the treatment with TNFαI, serum levels of ADAMTS-4, ADAMTS-5 and TIMP-3 were significantly higher in RA women than in healthy subjects (p < 0.001 for all comparisons; Figure 4a–c). Here, ADAMTS5 is linked to rheumatoid arthritis.